Rallybio Corp. (RLYB)
0.7722
-0.01
(-0.72%)
USD |
NASDAQ |
Dec 19, 16:00
0.7722
0.00 (0.00%)
After-Hours: 17:02
Rallybio EPS Diluted (Quarterly): 0.3554 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.363 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.02M |
| Revenue (Quarterly) | 0.212M |
| Total Expenses (Quarterly) | -15.80M |
| Enterprise Value | -26.26M |
| Gross Profit Margin (Quarterly) | 83.49% |
| Earnings Yield | -41.32% |
| Normalized Earnings Yield | -34.45 |